Master of International Translational Medicine

Apply Now

Admissions
Master of International Translational Medicine

in partnership with Eureka Institute

The Duke-NUS Master of International Translational Medicine (MITM) is a unique opportunity to learn from those directly involved in Translational Medicine (TM); engaging with world leading experts through our partnership with the Eureka Institute for Translational Medicine.

What is the Duke-NUS MITM programme?

Duke-NUS MITM is a two-year part-time, executive-style programme, designed to be compatible for those in full-time employment. The MITM Curriculum touches on the entire spectrum of the TM journey. MITM has been created to equip healthcare researchers and professionals with the skills and competencies necessary for effectively and efficiently progress discoveries and innovations towards patient care solutions.

Why choose the Duke-NUS MITM programme?

The MITM Programme is a unique opportunity to learn from those involved in TM - giving you the chance to interact directly with those who have experienced the trials and errors whilst being on the TM journey. You will get to engage with world leading experts through our partnership with the Eureka Institute for Translational Medicine. The programme extends beyond learning content alone, and intentionally fosters and enhances professional competencies required to be successful in TM, including creative thinking skills, leadership, teamwork, communications, and presentation skills.

Who is this programme for?

MITM caters to those who seek to address unmet needs and opportunities through technology and collaboration. This programme is aimed at those who seek to gain knowledge and tools necessary for the TM journey, for example, entrepreneurs, lawyers, or patient advocates.

For more information on the programme, download the MITM brochure.

For enquiries on MITM, please email raihan.jumat@duke-nus.edu.sg, register your interest in our mailing list or schedule an online meeting with a faculty member.

Frequently asked questions

Can I work full-time while enrolled in the MITM?

YES. The MITM is a part-time programme designed with the working professional in mind.

What are the MITM classes like?

The programme is comprised of engaging, evidence-based educational strategies delivered virtually, typically on Tuesday or Wednesday evenings from 6:00-10:00pm, weekly. In addition, once each year, there is a week-long course held on or near the Duke-NUS campus.

Prior to each weekly session, reading materials will be shared as necessary preparatory work to lay the foundation required.

How much does the MITM cost?

Tuition is $25,000 SGD per year, for two years.

Is there tuition support available?

The MITM is a self-pay degree programme. If you wish to explore tuition support below are possible avenues:

1. If you are a Singaporean or Singapore Permanent Resident, you may apply for tuition support from the NMRC Research Training Fellowship programme. There are 2 possible NMRC RTF application periods annually - once in JAN and another in JUL of each year. For full details and specific application window periods, please visit to the NMRC Research Training Fellowship Website

2. If you are an employee of SingHealth, you may approach your SingHealth Duke-NUS Academic Clinical Programme (ACP) Chair or Head of Department (HOD) to explore possibilities of tuition support. We strongly encourage that in-principle approval is obtained prior to applying for MITM.

3. NUS Executive & Administrative staff may apply for the NUS Masters Sponsorship scheme.

4. Applicants may also refer to Scholarships and Financial Aid Schemes offered by NUS.

How is the Duke-NUS MITM different than the NUS MSc in Translational Research & Innovation?

NUS offers an MSc in Translational Research & Innovation that focuses on training scientists and leads graduates to have the technical competence to support a research project under minimal supervision. The focus of the MITM, on the other hand, is on developing scientists and other stakeholders to be able to navigate the translational medicine landscape in order to better ensure that scientific discoveries make their way to patients efficiently and expeditiously.